Novartis suspected of corruption
Swiss pharmaceutical giant Novartis is under investigation in South Korea, a spokeswoman for the company told swissinfo.ch on Monday via email.
“We can confirm that the headquarters of Novartis Korea in Seoul were visited by local authorities in relation to an investigation on Feb 22, 2016,” she wrote.
According to media reports, Novartis is suspected of offering bribes to local doctors in the form of rebates for products.
The spokeswoman from the Novartis Media Relations department said that Novartis “is committed to high standards of ethical business conduct and regulatory compliance in all aspects of our work and we take any allegation of misconduct extremely seriously.”
The company is “cooperating fully with the authorities and will continue to support the investigation as requested,” she wrote. “We cannot comment further on this ongoing investigation.”
More
Why cars still reign supreme in ‘rail-nation’ Switzerland
More
Azeri fossil-fuel cash cow brings controversy to Switzerland
More
Taxes on pension payments: no problem for the Swiss Abroad
More
Is Switzerland as innovative as it ranks?
More
Swiss reject plans for bigger motorways and extra rights for landlords
In compliance with the JTI standards
More: SWI swissinfo.ch certified by the Journalism Trust Initiative
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.